Clinical Trial Update: Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease

View source ↗

Summary

This ClinicalTrials.gov entry reports a completed study examining microbiome-mediated gut dysfunction in non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Non-Alcoholic Fatty Liver Disease | Status: COMPLETED